제품 세부정보
Synonym
CEACAM-5, CD66e, CEA, Meconium antigen 100
Source
Human CEACAM-5, Llama IgG2b Fc Tag (CE5-H5259) is expressed from human 293 cells (HEK293). It contains AA Pro 593 - Ser 675 (Accession # P06731-1).
Predicted N-terminus: Pro 593
Request for sequenceMolecular Characterization

Other Tags and Version Biotin & Other Labeled Version
This protein carries a llama IgG2b Fc tag at the C-terminus.
The protein has a calculated MW of 36.7 kDa. The protein migrates as 50-60 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
Endotoxin
Less than 0.01 EU per μg by the LAL method / rFC method.
Purity
>95% as determined by SDS-PAGE.
Formulation
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
Reconstitution
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
Storage
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
- -20°C to -70°C for 12 months in lyophilized state;
- -70°C for 3 months under sterile conditions after reconstitution.
ACRO Quality Management System
고객님도 확인한 상품
데이터 표시
SDS-PAGE

Human CEACAM-5, Llama IgG2b Fc Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95%.
SEC-MALS

The purity of Human CEACAM-5, Llama IgG2b Fc Tag (Cat. No. CE5-H5259) is more than 85% and the molecular weight of this protein is around 80-108 kDa verified by SEC-MALS.
Report
Bioactivity-ELISA

Immobilized Human CEACAM-5, Llama IgG2b Fc Tag (Cat. No. CE5-H5259) at 1 μg/mL (100 μL/well) can bind Anti-CEACAM-5 (labetuzumab) Antibody, Human IgG1 with a linear range of 0.01-0.313 μg/mL (QC tested).
Protocol
사용자 리뷰 댓글 남기기

배경 소개
프론티어 진행
- 영어 이름:
Carcinoembryonic antigen related cell adhesion molecule 5
- 카테고리:
- 상장 의약품 수:
0 상세
- 임상 의약품 수:
18 상세
- 최고 개발 단계:
Phase 3 Clinical
전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521



















